Cholesterol depletion and genistein as tools to promote F508delCFTR retention at the plasma membrane

Cellular Physiology and Biochemistry

Volumn 20, Issue 5, 2007, Pages 473-482

  Lim, Christina H ^a   Bijvelds, Marcel J ^a   Nigg, Alex ^a   Schoonderwoerd, Kees ^a   Houtsmuller, Adriaan B ^a   De Jonge, Hugo R ^a   Tilly, Ben C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

CFTR; Chloride channel; Cholesterol; Cystic Fibrosis; Endocytosis; Genistein; Niemann Pick type C

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; CHOLESTEROL; FILIPIN; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; FORSKOLIN; GENISTEIN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL CELL; ANION TRANSPORT; ARTICLE; CELL CULTURE; CELL MEMBRANE; CHOLESTEROL METABOLISM; CONTROLLED STUDY; CYSTIC FIBROSIS; ENDOCYTOSIS; FIBROBLAST; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING;

EID: 34548345774     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000107531     Document Type: Article

References (51)

1. Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, Buchwald M, Tsui LC: Identification of the cystic fibrosis gene: genetic analysis. Science 1989;245:1073-1080.
2. Anderson MP, Gregory RJ, Thompson S, Souza DW, Paul S, Mulligan RC, Smith AE, Welsh MJ: Demonstration that CFTR is a chloride channel by alteration of its anion selectivity. Science 1991;253:202-205.
3. Golin-Bisello F, Bradbury N, Ameen N: STa and cGMP stimulate CFTR translocation to the surface of villus enterocytes in rat jejunum and is regulated by protein kinase G. Am J Physiol Cell Physiol 2005;289:708-716.
4. Bobadilla JL, Macek Jr M, Jason P, Fine JP, Farrell PM: Cystic fibrosis: a worldwide analysis of CFTR mutations-correlation with incidence data and application to screening. Hum Mutat 2002;19:575-606.
5. Cheng SH, Gregory RJ, Marshall J, Paul S, Souza DW, White GA, O'Riordan CR, Smith AE: Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 1990;63:827-834.
6. Denning GM, Ostedgaard LS, Welsh MJ: Abnormal localization of cystic fibrosis transmembrane conductance regulator in primary cultures of cystic fibrosis airway epithelia. J Cell Biol 1992;118:551-559.
7. Haws CM, Nepomuceno IB, Krouse ME, Wakelee H, Law T, Xia Y, Nguyen H, Wine JJ: Delta F508-CFTR channels: kinetics, activation by forskolin, and potentiation by xanthines. Am J Physiol 1996;270:1544-1555.
8. Lukacs GL, Chang XB, Bear C, Kartner N, Mohamed A, Riordan JR, Grinstein S: The delta F508 mutation decreases the stability of cystic fibrosis transmembrane conductance regulator in the plasma membrane. Determination of functional half-lives on transfected cells. J Biol Chem 1993;268:21592-21598.
9. Li C, Ramjeesingh M, Reyes E, Jensen T, Chang X, Rommens JM, Bear CE: The cystic fibrosis mutation (delta F508) does not influence the chloride channel activity of CFTR. Nat Genet 1993;3:311-316.
10. Gregory RJ, Rich DP, Cheng SH, Souza DW, Paul S, Manavalan P, Anderson MP, Welsh MJ, Smith AE: Maturation and function of cystic fibrosis transmembrane conductance regulator variants bearing mutations in putative nucleotide-binding domains 1 and 2. Mol Cell Biol 1991;11:3886-3893.
11. Sheppard DN, Rich DP, Ostedgaard LS, Gregory RJ, Smith AE, Welsh MJ: Mutations in CFTR associated with mild-disease-form Cl- channels with altered pore properties. Nature 1993;362:160-164.
12. Dalemans W, Barbry P, Champigny G, Jallat S, Dott K, Dreyer D, Crystal RG, Pavirani A, Lecocq JP, Lazdunski M: Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation. Nature 1991;354:526-528.
13. Sharma M, Pampinella F, Nemes C, Benharouga M, So J, Du K, Bache KG, Papsin B, Zerangue N, Stenmark H, Lukacs GL: Misfolding diverts CFTR from recycling to degradation: quality control at early endosomes. J Cell Biol 2004;164:923-933.
14. Gentzsch M, Chang XB, Cui L, Wu Y, Ozols VV, Choudhury A, Pagano RE, Riordan JR: Endocytic trafficking routes of wild type and DeltaF508 cystic fibrosis transmembrane conductance regulator. Mol Biol Cell 2004;15:2684-2696.
15. Subtil A, Gaidarov I, Kobylarz K, Lampson MA, Keen JH, McGraw TE: Acute cholesterol depletion inhibits clathrin-coated pit budding. Proc Natl Acad Sci USA 1999;96:6775-6780.
16. Rodal SK, Skretting G, Garred O, Vilhardt F, van Deurs B, Sandvig K: Extraction of cholesterol with methyl-beta-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles. Mol Biol Cell 1999;10:961-974.
17. Pike LJ, Casey L: Cholesterol levels modulate EGF receptor-mediated signaling by altering receptor function and trafficking. Biochemistry 2002;41:10315-10322.
18. Lim CH, Schoonderwoerd K, Kleijer WJ, de Jonge HR, Tilly BC: Regulation of the cell swelling-activated chloride conductance by cholesterol-rich membrane domains. Acta Physiol (Oxf) 2006;187:295-303.
19. White NM, Corey DA, Kelley TJ: Mechanistic similarities between cultured cell models of cystic fibrosis and Niemann-Pick type C. Am J Respir Cell Mol Biol 2004;31:538-543.
20. White NM, Jiang D, Burgess JD, Bederman IR, Previs SF, Kelley TJ: Altered cholesterol homeostasis in cultured and in vivo models of cystic fibrosis. Am J Physiol Lung Cell Mol Physiol 2007;292:476-486.
21. Berger HA, Anderson MP, Gregory RJ, Thompson S, Howard PW, Maurer RA, Mulligan R, Smith AE, Welsh MJ: Identification and regulation of the cystic fibrosis transmembrane conductance regulator-generated chloride channel. J Clin Invest 1991;88:1422-1431.
22. Vaandrager AB, Bajnath R, Groot JA, Bot AG, De Jonge HR: Ca2+ and cAMP activate different chloride efflux pathways in HT-29.cl19A colonic epithelial cell line. Am J Physiol 1991;261:958-965.
23. Ko DC, Gordon MD, Jin JY, Scott MP: Dynamic movements of organelles containing Niemann-Pick C1 protein: NPC1 involvement in late endocytic events. Mol Biol Cell 2001;12:601-614.
24. rd , Vanier MT, Patterson MC, Brady RO, Pentchev PG, Blanchette-Mackie EJ: The Niemann-Pick C1 protein resides in a vesicular compartment linked to retrograde transport of multiple lysosomal cargo. J Biol Chem 1999;274:9627-9635.
25. Choudhury A, Sharma DK, Marks DL, Pagano RE: Elevated endosomal cholesterol levels in Niemann-Pick cells inhibit rab4 and perturb membrane recycling. Mol Biol Cell 2004;15:4500-4511.
26. Wojtanik KM, Liscum L: The transport of low density lipoprotein-derived cholesterol to the plasma membrane is defective in NPC1 cells. J Biol Chem 2003;278:14850-14856.
27. Levitan I., Christian AE, Tulenko TN, Rothblat GH: Membrane cholesterol content modulates activation of volume-regulated anion current in bovine endothelial cells. J Gen Physiol 2000;115:405-416.
28. Romanenko VG, Rothblat GH, Levitan I: Modulation of endothelial inward-rectifier K+ current by optical isomers of cholesterol. Biophys J 2002;83:3211-3222.
29. Romanenko VG, Rothblat GH, Levitan I: Sensitivity of volume-regulated anion current to cholesterol structural analogues. J Gen Physiol 2004; 23:77-87.
30. Sharma DK, Brown JC, Choudhury A, Peterson TE, Holicky E, Marks DL, Simari R, Parton RG, Pagano RE: Selective stimulation of caveolar endocytosis by glycosphingolipids and cholesterol. Mol Biol Cell 2004;5:3114-3122.
31. Bradbury NA, Cohn JA, Venglarik CJ, Bridges RJ: Biochemical and biophysical identification of cystic fibrosis transmembrane conductance regulator chloride channels as components of endocytic clathrin-coated vesicles. J Biol Chem 1994;269:8296-302.
32. Lukacs GL, Segal G, Kartner N, Grinstein S, Zhang F: Constitutive internalization of cystic fibrosis transmembrane conductance regulator occurs via clathrin-dependent endocytosis and is regulated by protein phosphorylation. Biochem J 1997;328:353-361.
33. Prince LS, Workman RB Jr, Marchase RB: Rapid endocytosis of the cystic fibrosis transmembrane conductance regulator chloride channel. Proc Natl Acad Sci USA 1994;91:5192-5196.
34. Swiatecka-Urban A, Brown A, Moreau-Marquis S, Renuka J, Coutermarsh B, Barnaby R, Karlson KH, Flotte TR, Fukuda M, Langford GM, Stanton BA: The short apical membrane half-life of rescued {Delta}F508-cystic fibrosis transmembrane conductance regulator (CFTR) results from accelerated endocytosis of {Delta}F508-CFTR in polarized human airway epithelial cells. J Biol Chem 2005; 80:36762-36772.
35. Picciano JA, Ameen N, Grant BD, Bradbury NA: Rme-1 regulates the recycling of the cystic fibrosis transmembrane conductance regulator. Am J Physiol Cell Physiol 2003;5:1009-1018.
36. Egan ME, Schwiebert EM, Guggino WB: Differential expression of ORCC and CFTR induced by low temperature in CF airway epithelial cells. Am J Physiol 1995;268:243-251.
37. Brown CR, Hong-Brown LQ, Biwersi J, Verkman AS, Welch WJ: Chemical chaperones correct the mutant phenotype of the delta F508 cystic fibrosis transmembrane conductance regulator protein. Cell Stress Chaperones 1996;1:117-125.
38. Sato S, Ward CL, Krouse ME, Wine JJ, Kopito RR: Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation. J Biol Chem 1996;271:635-638.
39. Schmitz G, Buechler C: ABCA1: regulation, trafficking and association with heteromeric proteins. Ann Med 2002;34:334-347.
40. Ioannou YA: Guilty until proven innocent: the case of NPC1 and cholesterol. Trends Biochem Sci 2005;30:498-505.
41. French PJ, Bijman J, Bot AG, Boomaars WE, Scholte BJ, de Jonge HR: Genistein activates CFTR Cl- channels via a tyrosine kinase- and protein phosphatase-independent mechanism. Am J Physiol 1997;273:747-753.
42. Wang F, Zeltwanger S, Yang IC, Nairn AC, Hwang TC: Actions of genistein on cystic fibrosis transmembrane conductance regulator channel gating. Evidence for two binding sites with opposite effects. J Gen Physiol 1998;111:477-490.
43. Melin P, Thoreau V, Norez C, Bilan F, Kitzis A, Becq F: The cystic fibrosis mutation G1349D within the signature motif LSHGH of NBD2 abolishes the activation of CFTR chloride channels by genistein. Biochem Pharmacol 2004;67(12):2187-2196.
44. Schillers H, Danker T, Madeja M, Oberleithner H: Plasma membrane protein clusters appear in CFTR-expressing Xenopus laevis oocytes after cAMP stimulation. J Membr Biol 2001;180:205-12.
45. Lehrich RW, Aller SG, Webster P, Marino CR, Forrest JN Jr: Vasoactive intestinal peptide, forskolin, and genistein increase apical CFTR trafficking in the rectal gland of the spiny dogfish, Squalus acanthias. Acute regulation of CFTR trafficking in an intact epithelium. J Clin Invest 1998;101:737-745.
46. Bradbury NA, Jilling T, Berta G, Sorscher EJ, Bridges RJ, Kirk KL: Regulation of plasma membrane recycling by CFTR. Science 1992;256:530-532.
47. Salazar G, Gonzalez A: Novel mechanism for regulation of epidermal growth factor receptor endocytosis revealed by protein kinase A inhibition. Mol Biol Cell 2002;13:1677-1693.
48. Parker EM, Zaman MM, Freedman SD: GP2, a GPI-anchored protein in the apical plasma membrane of the pancreatic acinar cell, co-immunoprecipitates with src kinases and caveolin. Pancreas 2000;21:219-925.
49. Dorin JR, Farley R, Webb S, Smith SN, Farini E, Delaney SJ, Wainwright BJ, Alton E W. Porteous DJ: A demonstration using mouse models that successful gene therapy for cystic fibrosis requires only partial gene correction. Gene Ther 1996;3:797-801.
50. Dickinson P, Smith SN, Webb S, Kilanowski FM, Campbell IJ, Taylor MS, Porteous DJ, Willemsen R, de Jonge HR, Farley R, Alton EW, Dorin JR: The severe G480C cystic fibrosis mutation, when replicated in the mouse, demonstrates mistrafficking, normal survival and organ-specific bioelectrics. Hum Mol Genet 2002;11:243-251.
51. Charizopoulou N, Wilke M, Dorsch M, Bot A, Jorna H, Jansen S, Stanke F, Hedrich HJ, de Jonge HR, Tummler B: Spontaneous rescue from cystic fibrosis in a mouse model. BMC Genetics 2006,7:18.